Fairvalue-Calculator Fairvalue-Calculator
EN DE

BenQ Medical Technology Corporation (4116) Fair Value & Analysis

Healthcare · TW · Market cap 1.7B TWD

Price37.75 TWD
Fair Value38.59 TWD
Upside+2.2%
Quality80/100
Evidence: Medium Range 28.94 TWD – 48.24 TWD

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

BenQ Medical Technology Corporation (4116) currently trades at 37.75 TWD, while our model-based Fair Value estimate is 38.59 TWD — implying the stock looks roughly 2.2% undervalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

BenQ Medical Technology Corporation engages in the manufacture, installation, maintenance, and repair of medical device and various medical equipment in Taiwan, Mainland China, India, and internationally. It operates through R&D and Manufacturing, and Medical Services segments. The company offers wholesale and retail sales of medical device, medical equipment, pharmaceutical, health food, and the leasing business of medical equipment and management consulting services. It also offers electric hydraulic and manual hydraulic operating table, and operating table accessories; adjustable color temperature and single-color temperature surgical light; fixed pendant, electric pendant, and ICU suspension bridge; diagnostic display, and surgical display monitor; and portable ultrasound units, as well as it offers integrated operating system solutions. The company was formerly known as Trident Medical Corp. and changed its name to BenQ Medical Technology Corporation in June 2011. BenQ Medical …

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is BenQ Medical Technology Corporation (4116) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 38.59 TWD versus a price of 37.75 TWD — about +2% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 4116?
Our 21-model fair value for BenQ Medical Technology Corporation is 38.59 TWD (as of Jun 25, 2026), built from audited fundamentals. The current price is 37.75 TWD.
What is the quality score of 4116?
BenQ Medical Technology Corporation has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.